customer.service@microbix.com 
+1-905-361-8910 +1-800-794-6694 (Toll Free)
NEWS RELEASES
Microbix Announces Extension of Warrant Expiry Date
Applies for 12-month Term Extension of May 2021 Warrants MISSISSAUGA, CANADA, May 18, 2023 - Microbix Biosystems Inc. (TSX: MBX, OTCQB:...
Microbix Secures Funded Drug Commercialization Agreement
Kinlytic® urokinase to be developed for re-entry into U.S. market MISSISSAUGA, CANADA, May 16, 2023 – Microbix Biosystems Inc. (TSX: MBX,...
Microbix Reports Results for Q2 Fiscal 2023
Sales of $4.2 million and Profitability MISSISSAUGA, May 11, 2023 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life...
Microbix Presenting at the 2023 Bloom Burton Conference
MISSISSAUGA, CANADA, April 20, 2023 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator,...
Microbix Announces Annual and Special Meeting Voting Results
MISSISSAUGA, March 30, 2023 - Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF)( “Microbix®” or the Company”), a life sciences innovator,...
Microbix Annual General Meeting (AGM) Update
Remote Access to the AGM Provided to Avoid Physical Attendance MISSISSAUGA, CANADA, March 22, 2023 - Microbix Biosystems Inc. (TSX: MBX,...
Governments of Ontario and Canada Invest in Microbix
$ 1.68 Million in Funding for Capabilities and Capacity Expansions MISSISSAUGA, CANADA, March 20, 2023 – Microbix Biosystems Inc. (TSX:...
Microbix Supporting Australian Point-of-Care Testing Program
QAPs used in Diagnostic Testing for STIs in Remote Communities MISSISSAUGA, CANADA, March 1, 2023 – Microbix Biosystems Inc. (TSX: MBX,...
Microbix Announces Issuance of Stock Options
Using Shareholder-Approved Plan to Incentivize and Retain MISSISSAUGA, CANADA, February 27, 2023 - Microbix Biosystems Inc. (TSX: MBX,...
Microbix Reports Results for Q1 Fiscal 2023
Sales of $2.5 million, Net Loss of $1.3 million MISSISSAUGA, February 9, 2023 - Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF,...
Microbix Presenting Results of Collaboration with Health PEI
QAPs for HPV Test Verification within Cervical Cancer Screening Program MISSISSAUGA, CANADA, February 6, 2023 – Microbix Biosystems Inc....
Microbix Launches QAP to Support “Monkeypox” Testing
Driven by Customer Requests, Mpox Test Control Now Available MISSISSAUGA, CANADA, January 30, 2023 – Microbix Biosystems Inc. (TSX: MBX,...
